[Answered] Post tests are only needed if H0 is rejected in an ANOVA comparing more than 2 treatments. ...

This topic contains a solution. Click here to go to the answer

Author Question: Post tests are only needed if H0 is rejected in an ANOVA comparing more than 2 treatments. ... (Read 37 times)

cagreen833

Hero Member
Posts: 544

on: Jun 20, 2018

Post tests are only needed if H0 is rejected in an ANOVA comparing more than 2 treatments.

Indicate whether the statement is true or false

Question 2

For a sample with M = 20 and s = 1, a score of X = 17 would be considered an extremely low score.

Indicate whether the statement is true or false

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

janeli

Sr. Member
Posts: 346

Reply #1 on: Jun 20, 2018

Answer to Question 1

True

Answer to Question 2

True

cagreen833

Member
Posts: 544

Reply 2 on: Jun 20, 2018

YES! Correct, THANKS for helping me on my review

ryhom

Member
Posts: 366

Reply 3 on: Yesterday

Great answer, keep it coming

« previous next »

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.